“I’m excited to work with the talented team we’ve put together, combining expertise that allows us to apply cutting-edge single-cell technology to understand the intracellular signaling underlying T cell dysfunction. Hopefully, the insights this work uncovers will help improve immunotherapy outcomes for patients.”